Atrial fibrillation, or Afib, is the most common type of heart arrhythmia. Afib increases your risk of heart attack and ...

A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help ...

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia ...

The bidirectional research examines both laboratory findings and human clinical trial data, revealing that the medicinal use ...

While substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short ...

If – God forbid – I show the biomarkers associated with the probable development of Alzheimer’s, I will receive three doses ...

Ocugen has announced positive Phase 1 trial results for OCU410, a one-time gene therapy for geographic atrophy secondary to ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.

The U.S. Department of Labor’s Wage and Hour Division issued an opinion letter on Nov. 8, 2024, affirming that employees may use Family and ...

Novotech, the global full-service clinical CRO, has published a new report, Small Cell Lung Cancer: Global Clinical Trial ...

Neurogene (NGNE) announced an update on its ongoing Phase 1/2 open-label clinical trial evaluating NGN-401 gene therapy for the treatment of ...